UVXY News Alert Ultra VIX Short-Term Fut ETF Proshares (UVXY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra VIX Short-Term Fut ETF Proshares (UVXY) 18.91 $UVXY

The Best Offense Is A Good Defense: Profiting From Hedging
AllAboutAlpha - Seeking Alpha - 1 hr 46 mins ago
This time of year one often encounters certain football-fans' truisms. Sometimes one is told "the best defense is a good offense." At other times, "the best offense is a good defense." At yet other times, "it's all in the...
TVIX: 2.15 (-0.03), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

Doing The Unthinkable: Going Long Volatility
Josh Arnold - at Seeking Alpha - Thu Dec 04, 2:47AM CST

TVIX: 2.15 (-0.03), VXX: 26.54 (+0.02), UVXY: 18.91 (+0.07), XIV: 39.38 (-0.05)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 4:37PM CST

GWRE: 50.73 (unch), BV: 7.79 (+0.06), GASL: 5.43 (-0.63), MPLX: 67.65 (-0.74), UVXY: 18.91 (+0.07), OVTI: 26.54 (-0.01), GOL: 5.37 (+0.08), DNR: 7.67 (-0.07), REI: 9.34 (+0.42), PBYI: 195.55 (-2.12)

The Curious Case Of Elevated Volatility (Weight Of Evidence, Part 2 Of 7)
360 Investment Research - at Seeking Alpha - Tue Nov 18, 2:33PM CST
"Fear tends to manifest itself much quicker than greed, so volatile markets tend to be on the downside. In up markets, volatility tends to gradually decline." ~ Philip Roth The CBOE Volatility Index is often referred to as the FEAR Index....
TVIX: 2.15 (-0.03), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

Contrarian Eats Crow Over Decay Of Two Hedges That Protect Against Coming Dollar And Market Corrections
Bart Gruzalski - at Seeking Alpha - Fri Nov 14, 9:30AM CST

TVIX: 2.15 (-0.03), UVXY: 18.91 (+0.07)

Contrarian Delight: Maybe Last Chance To Invest Or Hedge With UVXY At All Time Lows
Bart Gruzalski - at Seeking Alpha - Fri Nov 07, 4:36PM CST

UVXY: 18.91 (+0.07)

Overcrowded Trade Du Jour: Short Volatility
Jesse Felder - Seeking Alpha - Tue Nov 04, 2:50PM CST
Periods of low volatility are to investors what a sweet lullaby sung by whispering nanny is to an overtired baby. It relaxes them, gets them to put their worries aside and believe that everything is going to be okay. Great for babies. Not so great...
TVIX: 2.15 (-0.03), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

The VIX And Seasonality: Long Live Santa Claus And The Turkey Gods
Force Majeure - Seeking Alpha - Mon Nov 03, 11:35AM CST
The month of October has certainly been a wild one for U.S. markets with the second half of the month the polar opposite of the first. The first two weeks were dominated by fear regarding global growth, ebola, and geopolitical instability and...
TVIZ: 19.64 (+0.23), TVIX: 2.15 (-0.03), SPY: 207.66 (-0.23), QQQ: 105.37 (-0.05), VXX: 26.54 (+0.02), UVXY: 18.91 (+0.07), VXZ: 12.29 (+0.08), XIV: 39.38 (-0.05)

Is The Latest VIX Decline A Trick Or Treat?
James Picerno - at Seeking Alpha - Thu Oct 30, 1:26PM CDT
It's nearly Halloween, but the frightening rise in U.S. stock market volatility earlier this month is looking less creepy at the moment. In particular, the Volatility Index (VIX) for the S&P 500 has tumbled substantially over the past week,...
TVIX: 2.15 (-0.03), ZIV: 44.79 (-0.68), VXX: 26.54 (+0.02), UVXY: 18.91 (+0.07), VXZ: 12.29 (+0.08), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

Climbing The Latest Wall Of Worry
Calafia Beach Pundit - Seeking Alpha - Tue Oct 28, 4:59PM CDT
As I mentioned about three weeks ago, stocks have been climbing walls of worry throughout the recovery which began some 5 ½ years ago. Almost every selloff in the past two years has been accompanied by/caused by an emotional response to new...
TVIX: 2.15 (-0.03), SPY: 207.66 (-0.23), QQQ: 105.37 (-0.05), VXX: 26.54 (+0.02), DIA: 178.83 (-0.13), UVXY: 18.91 (+0.07), XIV: 39.38 (-0.05)

Volatility Trade Back In Oct 22, 2014 - ETF Gainers And Losers
CapitalCube - Seeking Alpha - Thu Oct 23, 2:04PM CDT
By Veibha Subramaniam The risk-on trade seems to be back again. Buying volatility is back. Yesterday the market was buying the VIX and today as of 10:00 am the VIX ETFs are still gaining - VIXY (+7.84%), VXX (+7.67%), VIXM (+3.16%) The data was...
EGPT: 67.69 (+1.46), JO: 33.41 (-0.32), TZA: 13.30 (+0.20), VXX: 26.54 (+0.02), XOP: 49.33 (-1.67), GREK: 17.09 (+0.03), TNA: 75.73 (-1.16), UVXY: 18.91 (+0.07), HDGE: 11.44 (+0.08), PXI: 45.67 (-0.58), SRTY: 34.14 (+0.50), WIL: 53.09 (+0.35), VXZ: 12.29 (+0.08), XIV: 39.38 (-0.05), ERY: 20.69 (+0.54), GLDX: 10.38 (-0.52), ERX: 65.76 (-1.70), GDXJ: 25.69 (-0.63), JNUG: 3.42 (-0.28), FCG: 11.85 (-0.44), SGDM: 18.13 (-0.47), DUST: 24.72 (+0.41), ZSL: 110.96 (-0.03), JDST: 17.17 (+1.02), URTY: 86.98 (-1.27), SOXS: 13.07 (-0.05), TVIX: 2.15 (-0.03), UCO: 16.16 (-0.31), VIXM: 60.02 (+0.43), SIL: 9.28 (-0.27), NUGT: 13.29 (-0.75), SCO: 52.14 (+0.83), SVXY: 77.28 (-0.10), IPFF: 23.34 (+0.10), USLV: 22.61 (+0.12), RUSL: 6.24 (-0.52), SIZE: 65.70 (+0.28), VIXY: 17.71 (+0.06), PSCE: 29.12 (-1.00), FLGE: 115.03 (-0.30)

Not All Market Hedges Are Created Equal: Part 1
Invesco US - Seeking Alpha - Wed Oct 22, 3:20PM CDT
By John Feyerer While the multi-year bull market may feel like it has created some distance from the market turmoil, investors won't soon forget the global financial crisis of 2008-2009 and the eurozone debt crisis events of 2010-2011. These...
TVIZ: 19.64 (+0.23), TVIX: 2.15 (-0.03), XVZ: 29.40 (+0.14), VIXM: 60.02 (+0.43), XVIX: 16.63 (+0.13), ZIV: 44.79 (-0.68), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), CVOL: 0.93 (+0.01), VXZ: 12.29 (+0.08), VIIZ: 17.23 (-0.08), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

How To Hedge Using Volatility ETFs
Investing Crunch - Seeking Alpha - Wed Oct 22, 12:39PM CDT
By Carl Densem Only being able to buy and sell stocks can leave few options when markets head south as they have lately. One can either treat it as a buying opportunity, sell for fear of worse to come or wait it out. And though we like to trust...
TVIX: 2.15 (-0.03), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), PSQ: 58.64 (+0.01), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

Top 10 ETF Gainers And Losers For October 17, 2014
CapitalCube - Seeking Alpha - Sun Oct 19, 8:29AM CDT
By Veibha Subramaniam Top 10 ETF gainers with assets of more than $25 million as of Oct 17, 2014. (Non-Leveraged) The data was compiled using CapitalCube's ETF Screener Symbol Company 1 Day Price Return (%) Average Daily Volume...
JO: 33.41 (-0.32), VXX: 26.54 (+0.02), GREK: 17.09 (+0.03), XOP: 49.33 (-1.67), UVXY: 18.91 (+0.07), FIEU: 118.00 (-1.20), VXZ: 12.29 (+0.08), SDOW: 20.62 (+0.06), XIV: 39.38 (-0.05), SPXU: 37.94 (+0.15), EPV: 58.87 (+0.43), IDX: 25.26 (+0.07), SPXS: 20.58 (+0.05), GLDX: 10.38 (-0.52), SQQQ: 28.77 (+0.07), JNUG: 3.42 (-0.28), SGDM: 18.13 (-0.47), DZK: 64.65 (-0.75), GXF: 24.09 (-0.16), DUST: 24.72 (+0.41), GDX: 19.20 (-0.05), CURE: 134.47 (-0.55), JDST: 17.17 (+1.02), TVIX: 2.15 (-0.03), VIXM: 60.02 (+0.43), CFGE: 10.48 (+0.11), FEEU: 114.16 (-1.23), UXI: 117.89 (+0.58), SIL: 9.28 (-0.27), NUGT: 13.29 (-0.75), SVXY: 77.28 (-0.10), HEWG: 24.71 (-0.24), BXUC: 299.86 (unch), RUSL: 6.24 (-0.52), BRF: 23.80 (-0.27), EIDO: 27.76 (+0.12), EWZ: 39.13 (-0.74), UDOW: 143.67 (-0.20), VIXY: 17.71 (+0.06), ENOR: 24.74 (-0.30)

Another QE Would Be A Disaster
Orange Peel Investments - at Seeking Alpha - Fri Oct 17, 5:09PM CDT

SPY: 207.66 (-0.23), UVXY: 18.91 (+0.07), DIA: 178.83 (-0.13)

2008 Redux? - Part II
Travis McPherson - Seeking Alpha - Fri Oct 17, 7:22AM CDT
Ten days ago, before all the recent fun started, we penned a piece entitled " 2008 Redux? " The main point of this piece was to highlight the striking similarities between the current market and the lead up to the 2008 market meltdown. Most...
TVIX: 2.15 (-0.03), SPY: 207.66 (-0.23), VXX: 26.54 (+0.02), IVOP: 38.18 (+0.07), UVXY: 18.91 (+0.07), VIIX: 35.84 (unch), XXV: 38.36 (+0.02), VIXY: 17.71 (+0.06), SVXY: 77.28 (-0.10), XIV: 39.38 (-0.05)

With Volatility in the Stratosphere, Do You Know What the VIX Is?
at The Street - Wed Oct 15, 4:33PM CDT
It is important to recognize what the VIX is actually measuring, says Tim Edwards, director of Index Investment Strategy at S&P Dow Jones Indices.
SPY: 207.66 (-0.23), UVXY: 18.91 (+0.07), VIXY: 17.71 (+0.06)

Time For A 'Texas Hedge'?
Peter F. Way, CFA - at Seeking Alpha - Wed Oct 15, 11:23AM CDT

UVXY: 18.91 (+0.07), SVXY: 77.28 (-0.10)

Interesting UVXY Put And Call Options For November 7th
StockOptionsChannel.com - Thu Sep 25, 11:22AM CDT
Investors in Proshares Ultra VIX Short-Term Futures ETF saw new options become available today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the UVXY options chain for the new November...
UVXY: 18.91 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 78

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 97

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 185

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Pinterest Faces Legal Probe: Investor Concerns Rise

Updated Category News Views 95

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 133

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 108

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 157

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Alex Bastian Named VP of Commercial Strategy at Memo Therapeutics

Updated Category News Views 287

Alex Bastian Appointed as VP of Commercial Strategy at Memo Therapeutics AG Memo Therapeutics AG (or “MTx”), a late-stage biotech firm committed to transforming unique human immune responses into effective treatments for viral infections and cancer, has announced the appointment of Alex Bastian as its new VP of Commercial Strategy. Expertise in the Biotech Industry...

Continue Reading
AST SpaceMobile Partners with SDA to Advance Space Technology

Updated Category News Views 241

AST SpaceMobile's New Partnership with the Space Development Agency AST SpaceMobile, Inc. (NASDAQ: ASTS), a pioneering company in the development of the world's first space-based cellular broadband network, has made a significant stride by securing an initial contract with the Space Development Agency (SDA). This selection as a prime contractor represents a substantial...

Continue Reading
CIP Chemicals Market Set to Reach $3.69 Billion by 2029

Updated Category News Views 134

Exploring the Growth of the CIP Chemicals Market The CIP Chemicals Market is on an exciting trajectory, with projections indicating remarkable growth in the coming years. Analysts anticipate that the market will expand from USD 2.40 billion in 2024 to an impressive USD 3.69 billion by the year 2029. This growth signals a compound annual growth rate (CAGR) of 9.0%,...

Continue Reading
Rocket Lab Expands Partnership with iQPS for Future Missions

Updated Category News Views 217

Rocket Lab Partners with iQPS for Key Missions Rocket Lab USA, Inc. (Nasdaq: RKLB) has announced a significant contract with Institute for Q-shu Pioneers of Space, Inc. (iQPS), further solidifying its position as a leading provider of satellite launches. This new agreement includes three dedicated Electron missions, which will begin launching as early as 2026 from Rocket...

Continue Reading
Vinpai's Revenue and Growth Strategy: A 2024 Review

Updated Category News Views 111

Vinpai dropped its half-year numbers for 2024, and let me tell ya, it’s a mixed bag of good and bad. Sure, they reported a nice jump in sales—28% year-over-year to €5,111k—but you gotta dig deeper to see the cracks forming underneath that shiny surface. Revenue Growth vs. Margin Squeeze: What's the Real Deal? The revenue growth? That’s the feel-good story...

Continue Reading